Terms: = Lymphoma AND FIP1L1, DKFZp586K0717, 81608, ENSG00000145216, Q6UN15
35 results:
1. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
2. Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic lymphoma.
Paolino J; Dimitrov B; Apsel Winger B; Sandoval-Perez A; Rangarajan AV; Ocasio-Martinez N; Tsai HK; Li Y; Robichaud AL; Khalid D; Hatton C; Gillani R; Polonen P; Dilig A; Gotti G; Kavanagh J; Adhav AA; Gow S; Tsai J; Li Y; Ebert BL; Van Allen EM; Bledsoe J; Kim AS; Tasian SK; Cooper SL; Cooper TM; Hijiya N; Sulis ML; Shukla NN; Magee JA; Mullighan CG; Burke MJ; Luskin MR; Mar BG; Jacobson MP; Harris MH; Stegmaier K; Place AE; Pikman Y
Clin Cancer Res; 2023 Nov; 29(22):4613-4626. PubMed ID: 37725576
[TBL] [Abstract] [Full Text] [Related]
3. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
[TBL] [Abstract] [Full Text] [Related]
4. lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and fip1l1::PDGFRA rearrangement: Successful imatinib treatment in two cases.
Bellani V; Croci GA; Bucelli C; Maronese CA; Alberti S; Iurlo A; Cattaneo D
J Dermatol; 2023 Oct; 50(10):1330-1334. PubMed ID: 37248740
[TBL] [Abstract] [Full Text] [Related]
5. fip1l1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.
Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
[TBL] [Abstract] [Full Text] [Related]
6. [Complete remission of Loeffler's endocarditis with Imatinib in a myeloid and lymphoid neoplasm associated with eosinophilia].
Wienemann H; Bröckelmann PJ; Adam M
Dtsch Med Wochenschr; 2020 Jan; 145(1):36-39. PubMed ID: 31914467
[TBL] [Abstract] [Full Text] [Related]
7. Hypereosinophilic syndrome preceding a diagnosis of B-cell lymphoma.
Samarghandi A; Ahuja S; Jindal V; Gupta S; Fulger I
Tumori; 2018 Dec; 104(6):NP22-NP24. PubMed ID: 29714651
[TBL] [Abstract] [Full Text] [Related]
8. A neoplasm with fip1l1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.
Oberley MJ; Denton C; Ji J; Hiemenz M; Bhojwani D; Ostrow D; Wu S; Gaynon P; Raca G
Cancer Genet; 2017 Oct; 216-217():91-99. PubMed ID: 29025601
[TBL] [Abstract] [Full Text] [Related]
9. Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with fip1l1/PDGFRA fusion gene effectively treated with imatinib: A case report.
Yamamoto M; Ikuta K; Toki Y; Hatayama M; Shindo M; Torimoto Y; Okumura T
Medicine (Baltimore); 2017 Sep; 96(36):e8001. PubMed ID: 28885361
[TBL] [Abstract] [Full Text] [Related]
10. Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature.
Zhou J; Papenhausen P; Shao H
Int J Clin Exp Pathol; 2015; 8(5):5812-20. PubMed ID: 26191303
[TBL] [Abstract] [Full Text] [Related]
11. CD30+ clonal T-cell lymphoid proliferation of the skin in a patient with hypereosinophilic syndrome.
Kempf W; Kazakov DV; Szep Z; Vanecek T
J Cutan Pathol; 2015 Feb; 42(2):130-5. PubMed ID: 25421540
[TBL] [Abstract] [Full Text] [Related]
12. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.
Lefèvre G; Copin MC; Staumont-Sallé D; Avenel-Audran M; Aubert H; Taieb A; Salles G; Maisonneuve H; Ghomari K; Ackerman F; Legrand F; Baruchel A; Launay D; Terriou L; Leclech C; Khouatra C; Morati-Hafsaoui C; Labalette M; Borie R; Cotton F; Gouellec NL; Morschhauser F; Trauet J; Roche-Lestienne C; Capron M; Hatron PY; Prin L; Kahn JE;
Medicine (Baltimore); 2014 Oct; 93(17):255-266. PubMed ID: 25398061
[TBL] [Abstract] [Full Text] [Related]
13. Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma.
Jacobsen E; Pozdnyakova O; Redd R; Fisher DC; Dorfman DM; Dal Cin P; LaCasce A; Armand P; Hochberg E; Cote G; Shahsafaei A; Neuberg D; Brown JR; Freedman AS
Leuk Lymphoma; 2015 Apr; 56(4):993-8. PubMed ID: 25012943
[TBL] [Abstract] [Full Text] [Related]
14. Hes1 upregulation contributes to the development of fip1l1-PDGRA-positive leukemia in blast crisis.
Uchida T; Kitaura J; Nakahara F; Togami K; Inoue D; Maehara A; Nishimura K; Kawabata KC; Doki N; Kakihana K; Yoshioka K; Izawa K; Oki T; Sada A; Harada Y; Ohashi K; Katayama Y; Matsui T; Harada H; Kitamura T
Exp Hematol; 2014 May; 42(5):369-379.e3. PubMed ID: 24486648
[TBL] [Abstract] [Full Text] [Related]
15. The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.
Amrein PC
Leuk Lymphoma; 2011 May; 52(5):754-63. PubMed ID: 21463117
[TBL] [Abstract] [Full Text] [Related]
16. Molecular characterization of paediatric idiopathic hypereosinophilia.
Rapanotti MC; Caruso R; Ammatuna E; Zaza S; Trotta L; Divona M; Cicconi L; Funaro D; Federici G; Amadori S; De Rossi G; Lo-Coco F
Br J Haematol; 2010 Dec; 151(5):440-6. PubMed ID: 20955401
[TBL] [Abstract] [Full Text] [Related]
17. [ABL1, SRC and other non-receptor protein tyrosine kinases as new targets for specific anticancer therapy].
Klener P; Klener P
Klin Onkol; 2010; 23(4):203-9. PubMed ID: 20806817
[TBL] [Abstract] [Full Text] [Related]
18. Identification and characterization of novel oncogenes in chronic eosinophilic leukemia and T-cell acute lymphoblastic leukemia.
Cools J
Verh K Acad Geneeskd Belg; 2010; 72(1-2):55-70. PubMed ID: 20726440
[TBL] [Abstract] [Full Text] [Related]
19. Hypereosinophilic syndrome and proliferative diseases.
Ionescu MA; Wang L; Janin A
Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
[TBL] [Abstract] [Full Text] [Related]
20. The hypereosinophilic syndromes: current concepts and treatments.
Gleich GJ; Leiferman KM
Br J Haematol; 2009 May; 145(3):271-85. PubMed ID: 19243381
[TBL] [Abstract] [Full Text] [Related]
[Next]
